Last reviewed · How we verify
Aminaftone (aminaphthone)
Aminaftone (generic name: aminaphthone) is a drug. It is currently in unknown development.
Aminaftone works by interacting with specific biological pathways, but the exact mechanism is unknown.
Aminaphtone is being studied as a phlebotonic intervention for conditions such as hemorrhoids, iliac vein obstruction, May-Thurner Syndrome, and Cockett Syndrome. It is also being used in combination with lidocaine cream in a first-line therapy for hemorrhoidal disease.
At a glance
| Generic name | aminaphthone |
|---|---|
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like a complex orchestra, with many different instruments working together to create a symphony. Aminaftone is like a new instrument that's being introduced to the orchestra, but we don't yet know how it will fit in or what it will sound like. As researchers learn more about how aminaftone interacts with the cells, they can begin to understand how it might be used to treat certain conditions.
Approved indications
Common side effects
Key clinical trials
- ORal Aminaphtone and Combined LidocainE
- Iliac Vein Stenting in Advanced Chronic Venous Insufficiency (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aminaftone CI brief — competitive landscape report
- Aminaftone updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Aminaftone
What is Aminaftone?
How does Aminaftone work?
What is the generic name of Aminaftone?
What development phase is Aminaftone in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing